Maria Pia Donataccio1, Etienne Puymirat2, Biljana Parapid3, Philippe Gabriel Steg4, Hélène Eltchaninoff5, Simon Weber6, Emile Ferrari7, Didier Vilarem8, Sandrine Charpentier9, Stéphane Manzo-Silberman10, Jean Ferrières11, Nicolas Danchin1, Tabassome Simon12. 1. Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Department of Cardiology, Paris, France; Université Paris-Descartes, Paris France. 2. Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Department of Cardiology, Paris, France; Université Paris-Descartes, Paris France; INSERM U-970, Paris, France. Electronic address: etiennepuymirat@yahoo.fr. 3. Division of Cardiology, Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia. 4. AP-HP, Hôpital Bichat, Department of Cardiology, Paris, France; Université Paris Diderot-Paris VII, France; INSERM, U-698, Paris, France. 5. Hôpital Charles Nicolle, Department of Cardiology, Rouen, France; University of Rouen, France. 6. Université Paris-Descartes, Paris France; AP-HP, Hôpital Cochin, Department of Cardiology, Paris, France. 7. Pasteur Hospital, Department of Cardiology, University Hospital of Nice, Nice, France. 8. Valenciennes General Hospital, Department of Cardiology, Valenciennes, France. 9. Purpan University Hospital, Emergency Department, Toulouse, France; U1027, INSERM, France. 10. AP-HP, Hôpital Lariboisière, Department of Cardiology, Paris, France. 11. Toulouse Rangueil University Hospital, Department of Cardiology, France; UMR1027, INSERM, France. 12. AP-HP, Hôpital Saint Antoine, Department of Clinical Pharmacology, Paris, France; INSERM, U-698, Inserm, Paris, France; UPMC-Paris 06, France.
Abstract
BACKGROUND: The early mortality of acute myocardial infarction (AMI) has dramatically decreased in the recent past. Whether the previously reported sex disparities in use of invasive strategies (IS) persist and translate into differences in outcomes deserves to be examined. METHODS: We used the data from a nationwide French prospective multicentre registry from 3,670 AMI patients (1155 women (31.5%), 2515 men (68.5%)) recruited in 223 centres in 2005 and followed-up for 5 years. We examined in-hospital outcomes and 5-year mortality in patients categorized according to sex and use of IS (i.e. coronary angiography during the hospitalisation with a view to revascularisation). RESULTS: IS was less frequently used in women than in men (adjusted OR=0.66; 95% CI: 0.52-0.85), regardless of the type of AMI, age group or risk category, while use of recommended medications was similar at 48 hours and discharge. In-hospital mortality did not differ according to sex, whatever the age group and use of an IS. At 5 years, overall and post-discharge mortality were similar in men and women. However, IS was associated with lower 5-year mortality in women (HR=0.66; 95% CI: 0.51-0.86) as in men (HR=0.48; 95% CI: 0.38-0.60) and there was no sex-strategy interaction. CONCLUSIONS: Invasive strategy remains less frequently used in women than in men, yet is associated with improved five-year survival irrespective of sex. Whether reducing the sex gap in its use would translate into a higher survival in women remains an open question. CLINICAL TRIAL REGISTRATION: NCT 00673036.
RCT Entities:
BACKGROUND: The early mortality of acute myocardial infarction (AMI) has dramatically decreased in the recent past. Whether the previously reported sex disparities in use of invasive strategies (IS) persist and translate into differences in outcomes deserves to be examined. METHODS: We used the data from a nationwide French prospective multicentre registry from 3,670 AMI patients (1155 women (31.5%), 2515 men (68.5%)) recruited in 223 centres in 2005 and followed-up for 5 years. We examined in-hospital outcomes and 5-year mortality in patients categorized according to sex and use of IS (i.e. coronary angiography during the hospitalisation with a view to revascularisation). RESULTS: IS was less frequently used in women than in men (adjusted OR=0.66; 95% CI: 0.52-0.85), regardless of the type of AMI, age group or risk category, while use of recommended medications was similar at 48 hours and discharge. In-hospital mortality did not differ according to sex, whatever the age group and use of an IS. At 5 years, overall and post-discharge mortality were similar in men and women. However, IS was associated with lower 5-year mortality in women (HR=0.66; 95% CI: 0.51-0.86) as in men (HR=0.48; 95% CI: 0.38-0.60) and there was no sex-strategy interaction. CONCLUSIONS: Invasive strategy remains less frequently used in women than in men, yet is associated with improved five-year survival irrespective of sex. Whether reducing the sex gap in its use would translate into a higher survival in women remains an open question. CLINICAL TRIAL REGISTRATION: NCT 00673036.
Authors: Saraschandra Vallabhajosyula; Saarwaani Vallabhajosyula; Shannon M Dunlay; Sharonne N Hayes; Patricia J M Best; Jorge A Brenes-Salazar; Amir Lerman; Bernard J Gersh; Allan S Jaffe; Malcolm R Bell; David R Holmes; Gregory W Barsness Journal: Mayo Clin Proc Date: 2020-09 Impact factor: 7.616
Authors: Jacob A Udell; Maria Koh; Feng Qiu; Peter C Austin; Harindra C Wijeysundera; Akshay Bagai; Andrew T Yan; Shaun G Goodman; Jack V Tu; Dennis T Ko Journal: J Am Heart Assoc Date: 2017-01-20 Impact factor: 5.501
Authors: Dragana Radovanovic; Burkhardt Seifert; Marco Roffi; Philip Urban; Hans Rickli; Giovanni Pedrazzini; Paul Erne Journal: Open Heart Date: 2017-11-14
Authors: Łukasz Piątek; Krzysztof Wilczek; Jacek Kurzawski; Marek Gierlotka; Mariusz Gąsior; Lech Poloński; Marcin Sadowski Journal: Arch Med Sci Date: 2020-02-28 Impact factor: 3.318
Authors: Jessica Potts; Alex Sirker; Sara C Martinez; Martha Gulati; Mirvat Alasnag; Muhammad Rashid; Chun Shing Kwok; Joie Ensor; Danielle L Burke; Richard D Riley; Lene Holmvang; Mamas A Mamas Journal: PLoS One Date: 2018-09-04 Impact factor: 3.240
Authors: Oras A Alabas; Chris P Gale; Marlous Hall; Mark J Rutherford; Karolina Szummer; Sofia Sederholm Lawesson; Joakim Alfredsson; Bertil Lindahl; Tomas Jernberg Journal: J Am Heart Assoc Date: 2017-12-14 Impact factor: 6.106